Immunology and Microbiology Devices; Classification of Anti-Saccharomyces cerevisiae (S. cerevisiae) Antibody (ASCA) Test Systems. Food and Drug Administration, HHS. Final rule.
The Food and Drug Administration (FDA) is classifying the Anti-Saccharomyces cerevisiae (S. cerevisiae) antibody (ASCA) test system into class II (special controls).  The special control that will apply to this device is a guidance document entitled "Guidance for Industry and FDA Reviewers: Class II Special Control Guidance Document for Anti-Saccharomyces cerevisiae (S. cerevisiae) Antibody (ASCA) Premarket Notifications." Elsewhere in this issue of the Federal Register.  FDA is announcing the availability of this guidance document.  The agency is taking this action in response to a petition submitted under the Federal Food, Drug, and Cosmetic Act (the act) as amended by the Medical Device Amendments of 1976, the Safe Medical Devices Act of 1990, and the Food and Drug Administration Modernization Act of 1997.  The agency is classifying these devices into class II (special controls) in order to provide a reasonable assurance of the safety and effectiveness of the devices.
D000908:Antibodies, Fungal / Q000276:immunology; D003424:Crohn Disease / Q000097:blood; D018795:Device Approval / Q000331:legislation & jurisprudence; D004797:Enzyme-Linked Immunosorbent Assay / Q000145:classification; D006801:Humans; D012441:Saccharomyces cerevisiae / Q000276:immunology; D014481:United States; D014486:United States Food and Drug Administration
D000908:Antibodies, Fungal